Drug General Information
Drug ID	D0U3SY
Drug Name	Alectinib
Drug Type	Small molecular drug
Indication	Lung Cancer [ICD10:C33-C34]		Approved	[1572608]
	Discovery agent		Investigative	[1572605]
Structure		Download 2D MOL 3D MOL
Formula	C30H34N4O2
PubChem Compound ID	49806720
Drug Resistance Mutation (DRM)
DRM	DRM Info
References
Ref 1572605	The ChEMBL database in 2017.
Ref 1572608	Alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.